Biomarkers of inflammation in major vascular surgery: A prospective randomised trial

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 6, 2015, Pages 773-787

  Lindholm, E E ^a   Aune, E ^a   Seljeflot, I ^b,c   Otterstad, J E ^a   KirkebOen K A ^b,c  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPOFOL; REMIFENTANIL; SEVOFLURANE; VASCULAR CELL ADHESION MOLECULE 1; CARDIOTONIC AGENT; CYTOKINE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DESCENDING AORTA SURGERY; FEMALE; HEART PROTECTION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VASCULAR SURGERY; BLOOD; DRUG EFFECTS; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOTONIC AGENTS; CHEMOKINE CCL2; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 9; METHYL ETHERS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR SURGICAL PROCEDURES;

EID: 84930378411     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12466     Document Type: Article

References (67)

1. Frassdorf J, De Hert S, Schlack W,. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth 2009; 103: 89-98.
2. Symons JA, Myles PS,. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006; 97: 127-136.
3. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van RV, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE,. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310.
4. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE,. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101: 9-20.
5. Conzen PF, Fischer S, Detter C, Peter K,. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003; 99: 826-833.
6. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, Calabro MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torri G,. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21: 502-511.
7. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, De LM, Fochi O, D'Avolio S, Bignami E, Calabro MG, Zangrillo A,. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24: 323-331.
8. Zangrillo A, Testa V, Aldrovandi V, Tuoro A, Casiraghi G, Cavenago F, Messina M, Bignami E, Landoni G,. Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth 2011; 25: 902-907.
9. Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, Kasper J, Filipovic M, Bolliger D, Seeberger MD,. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation 2012; 126: 2696-2704.
10. Lindholm EE, Aune E, Noren CB, Seljeflot I, Hayes T, Otterstad JE, Kirkeboen KA,. Theanesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery. Anesthesiology 2013; 119: 802-812.
11. Lindholm E, Aune E, Froeland G, Kirkeboen KA, Otterstad JE,. The ABSENT echocardiographic study: a prospective randomized controlled trial comparing echocardiographic changes with fentanyl/sevoflurane vs propofol/remifentanil anaesthesia in major vascular surgery. Anaesthesia 2014; 69: 558-572.
12. Koenig A, Koenig UD, Heicappel R, Stoeckel H,. Differences in lymphocyte mitogenic stimulation pattern depending on anaesthesia and operative trauma: I. Halothane-nitrous oxide anaesthesia. Eur J Anaesthesiol 1987; 4: 17-24.
13. Helmy SA, Wahby MA, El-Nawaway M,. The effect of anaesthesia and surgery on plasma cytokine production. Anaesthesia 1999; 54: 733-738.
14. Lin E, Calvano SE, Lowry SF,. Inflammatory cytokines and cell response in surgery. Surgery 2000; 127: 117-126.
15. Hildebrand F, Pape HC, Krettek C,. [The importance of cytokines in the posttraumatic inflammatory reaction]. Unfallchirurg 2005; 108: 793-803.
16. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ,. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg 1997; 85: 1394-1398.
17. Kvarnstrom AL, Sarbinowski RT, Bengtson JP, Jacobsson LM, Bengtsson AL,. Complement activation and interleukin response in major abdominal surgery. Scand J Immunol 2012; 75: 510-516.
18. Schneemilch CE, Ittenson A, Ansorge S, Hachenberg T, Bank U,. Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery. J Clin Anesth 2005; 17: 517-527.
19. Galle C, De Maertelaer V, Motte S, Zhou L, Stordeur P, Delville JP, Li R, Ferreira J, Goldman M, Capel P, Wautrecht JC, Pradier O, Dereume JP,. Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. J Vasc Surg 2000; 32: 234-246.
20. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M,. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 1994; 6: 181-186.
21. Taniguchi Y,. Kinetics of the levels of pro- and anti-inflammatory cytokines and vascular endothelial growth factor in serum and pleural fluid after major lung resection for lung cancer. Yonago Acta Med 2002; 45: 49-57.
22. Kokot M, Biolik G, Ziaja D, Fojt T, Cisak K, Antoniak K, Pawlicki K, Ziaja K, Duława J,. Endothelium injury and inflammatory state during abdominal aortic aneurysm surgery: scrutinizing the very early and minute injurious effects using endothelial markers-a pilot study. Arch Med Sci 2013; 9: 479-486.
23. Kirman I, Jain S, Cekic V, Belizon A, Balik E, Sylla P, Arnell T, Forde KA, Whelan RL,. Altered plasma matrix metalloproteinase-9/tissue metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer. Surg Endosc 2006; 20: 482-486.
24. De Hert S, Longrois DG, Yang H, Fleisher LA,. Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesthesiol Belg 2008; 59: 19-25.
25. Baker EA, El-Gaddal S, Williams L, Leaper DJ,. Profiles of inflammatory cytokines following colorectal surgery: relationship with wound healing and outcome. Wound Repair Regen 2006; 14: 566-572.
26. Lindholm E, Seljeflot I, Aune E, Kirkeboen KA,. Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery. Transfusion 2012; 52: 1761-1769.
27. Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH,. The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms. J Vasc Surg 2010; 51: 1479-1487.
28. Holzheimer RG, Gross J, Schein M,. Pro- and anti-inflammatory cytokine-response in abdominal aortic aneurysm repair: a clinical model of ischemia-reperfusion. Shock 1999; 11: 305-310.
29. Baigrie RJ, Lamont PM, Whiting S, Morris PJ,. Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg 1993; 166: 248-251.
30. Lau LL, Halliday MI, Lee B, Hannon RJ, Gardiner KR, Soong CV,. Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxaemia and mucosal barrier dysfunction. Eur J Vasc Endovasc Surg 2000; 19: 619-624.
31. Haynes SL, Wong JC, Torella F, Dalrymple K, Pilsworth L, McCollum CN,. The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery. Eur J Vasc Endovasc Surg 2001; 22: 244-250.
32. Kopp E, Ghosh S,. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-959.
33. Beck G, Hanusch C, Brinkkoetter P, Rafat N, Schulte J, van Ackern K, Yard B,. [Effects of dopamine on cellular and humoral immune responses in septic patients]. Anaesthesist 2005; 54: 1012-1020.
34. Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL,. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care 2008; 36: 74-78.
35. Crozier TA, Muller JE, Quittkat D, Sydow M, Wuttke W, Kettler D,. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72: 280-285.
36. El Azab SR, Rosseel PMJ, De Lange JJ, van Wijk EM, van Strik R, Scheffer GJ,. Effect of VIMA with sevoflurane versus TIVA with propofol or midazolam-sufentanil on the cytokine response during CABG surgery. Eur J Anaesthesiol 2002; 19: 276-282.
37. Reutershan J, Chang D, Hayes JK, Ley K,. Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. Anesthesiology 2006; 104: 511-517.
38. De Conno E, Steurer MP, Wittlinger M, Zalunardo MP, Weder W, Schneiter D, Schimmer RC, Klaghofer R, Neff TA, Schmid ER, Spahn DR, Z'Graggen BR, Urner M, Beck-Schimmer B,. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology 2009; 110: 1316-1326.
39. Schilling T, Kozian A, Kretzschmar M, Huth C, Welte T, Buhling F, Hedenstierna G, Hachenberg T,. Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth 2007; 99: 368-375.
40. Kawamura T, Kadosaki M, Nara N, Kaise A, Suzuki H, Endo S, Wei J, Inada K,. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2006; 20: 503-508.
41. Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, Spahn DR, Zaugg M,. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005; 94: 159-165.
42. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R,. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 2009; 119: 2209-2216.
43. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ,. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996; 39: 1576-1587.
44. Yassen KA, Galley HF, Webster NR,. Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 2001; 56: 729-732.
45. Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones C, Schumpelick V,. Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 2005; 137: 229-234.
46. Volta CA, Alvisi V, Campi M, Marangoni E, Alvisi R, Castellazzi M, Fainardi E, Manfrinato MC, Dallocchio F, Bellini T,. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study. Anesthesiology 2007; 106: 85-91.
47. Li A, Dubey S, Varney ML, Dave BJ, Singh RK,. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003; 170: 3369-3376.
48. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S,. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997; 29: 419-423.
49. Constans J, Conri C,. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006; 368: 33-47.
50. Bielinski SJ, Pankow JS, Li N, Hsu FC, Adar SD, Jenny NS, Bowden DW, Wasserman BA, Arnett D,. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008; 201: 339-344.
51. Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI, Smith JD,. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 2001; 21: 1662-1667.
52. Corcoran TB, Engel A, Shorten GD,. The influence of propofol on the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in reoxygenated human umbilical vein endothelial cells. Eur J Anaesthesiol 2006; 23: 942-947.
53. Hofbauer R, Frass M, Gmeiner B, Sandor N, Schumann R, Wagner O, Kaye AD,. Effects of remifentanil on neutrophil adhesion, transmigration, and intercellular adhesion molecule expression. Acta Anaesthesiol Scand 2000; 44: 1232-1237.
54. Biao Z, Zhanggang X, Hao J, Changhong M, Jing C,. The in vitro effect of desflurane preconditioning on endothelial adhesion molecules and mRNA expression. Anesth Analg 2005; 100: 1007-1013.
55. Kokot M, Biolik G, Ziaja D, Fojt T, Cisak K, Antoniak K, Pawlicki K, Ziaja K, Dulawa J,. Endothelium injury and inflammatory state during abdominal aortic aneurysm surgery: scrutinizing the very early and minute injurious effects using endothelial markers-a pilot study. Arch Med Sci 2013; 9: 479-486.
56. Rotter V, Nagaev I, Smith U,. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278: 45777-45784.
57. Doi Y, Kiyohara Y, Kubo M, Tanizaki Y, Okubo K, Ninomiya T, Iwase M, Iida M,. Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama Study. Diabetes Care 2005; 28: 1211-1213.
58. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS,. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64.
59. Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, Esposito K, Szabõ C, Ceriello A,. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004; 2: 1453-1459.
60. Kamada H, Yu F, Nito C, Chan PH,. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007; 38: 1044-1049.
61. Lan CC, Wu CS, Huang SM, Wu IH, Chen GS,. High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: new insights into impaired diabetic wound healing. Diabetes 2013; 62: 2530-2538.
62. Sommer C, Kress M,. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004; 361: 184-187.
63. Haddad JJ,. On the enigma of pain and hyperalgesia: a molecular perspective. Biochem Biophys Res Commun 2007; 353: 217-224.
64. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M,. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93: 409-417.
65. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G,. Longlasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000; 92: 465-472.
66. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN,. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: e77-137. doi: 10.1016/j.jacc.2014.07.944; E-published 1st August 2014.
67. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Task ACCAHA, Force M, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW,. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: 1971-1996.